Real time PCR detection chromosomal translocation in lymphoma by special probe

Posted on by bm-jcc

crossMark
http://dx.doi.org/10.18081/jcc/016-06/28-33
Journal of Cellular Cancer  Volume 8, Issue 1, pages 28-33
Received January 21, 2016; accepted May 28, 2016; published June 28, 2016

Thana Mohammed Juda1*, Seenaa Badr1

Author Affiliations
*Corresponding Author: Electronic address: Thanaswedi@yahoo.com. ¹Babylon University /College of Medicine

Abstract

The research of malignancy was mostly reach to facts that the cancer is multifactorial, many risk factors are associated with developing of cancer in normal cell so we always need for a new and accurate methods in early diagnosis and identify persons susceptible for developing cancer and new technique need in follow up. One of important risk factor which are associated with developing cancer are mutation, in this work we study the association between the t(14;18) (q32;q21) translocation between BCL2 gene on chromosome 14 and immunoglobulin heavy chain on chromosome 18. Detection of this translocation can facilitate the diagnosis of follicular lymphoma and can be used to monitor response to therapy and level of residual disease. We here collect sample of non-Hodgkin lymphoma from lab in Babylon city  and we depend on paraffin embedded tissue as diagnosed by histopathologists, we extract DNA and prepare special primer for amplification the translocation and we depend on technique of real time PCR as diagnostic procedure for translocation detection by special probe (fam-tamra probe) which give positive signal in non-Hodgkin lymphoma and Burkett’s lymphoma by compares with control which are tonsil tissue which give negative signal which indicate that translocation can be considered as risk factor for developing lymphoma.

Keywords: Lymphoma; PCR; DNA; Multi factorial; Non-Hodgkin

Article citationReferencesFull-Text/PDFFeedback
The citation data is computed by the crosssref service:

citedby

References

  1. Stewart AK, Schuh AC. White cells2: impact of under- standing the molecular basis of haematological malignant disorders on clinical practice. Lancet 2000;355(9213):1447-53. [PubMed]
  2. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003;348(18):1777-85. [PubMed]
  3. Ekstrom K, Hjalgrim H, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first degree relatives. Arthritis & Rheumatism 2003;48(4):963-970. [Abstract/Full-text]
  4. Maeda E, Akahane M, Kiryu S, et al. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Japanese Journal of Radiology 2009;27(1):4-19. [PubMed]
  5. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. Journal of Hepatology 2003;59(1):169-177. [PubMed]
  6. Pinzone MR, Fiorica F, Di Rosa M, et al. Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci 20012;16(10):1377-88. [PubMed]
  7. Kramer S, Hikel SM, Adams K, Hinds D, Moon K. Current Status of the Epidemiologic Evidence Linking Polychlorinated Biphenyls and Non-Hodgkin Lymphoma, and the Role of Immune Dysregulation. Environmental Health Perspe-ctives 2012;120(8):1067-75. [PubMed]
  8. Zani C, Toninelli G, Filisetti B, Donato F. Polychlorinated biphenyls and cancer: an epidemiological assessment. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2013;31(2):99-144. [PubMed]
  9. Lauby-Secretan B, Loomis D, Grosse Y, et al. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet Oncology 2013;14(4):287-288. [Abstract/Full-text]
  10.  Mérino D, Bouillet P. The Bcl-2 family in autoimmune and degenerative disorders. Apoptosis 2009;14(4):570-83. [PubMed]
  11.  Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009;361:1570-1583. [PubMed]
  12.  KL, Bu R, Gascoyne RD, Connors JM, Spinelli JJ, Brooks-Wilson AR. Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma. Blood 2010;116(26):6146-7. [PubMed]
  13.  Yin CC1, Luthra R. Molecular detection of t(14;18)(q32;q21) in follicular lymphoma. Methods Mol Biol 2013;999:203-9. [PubMed]
  14.  Meng B, Sun B, Guan B, et al. Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses. Diagn Mol Pathol 2012;21(4):234-40. [PubMed]
  15.  German Ott, Rosenwald A. Molecular pathogenesis of follicular lymphoma. Haematologica 2008;93:1773-1776. [Abstract/Full-text]
  16.  Evens AM. Winter JN. Gordon LI. et al. In: Pazdur R, Wagman LD, Camphausen KA, HoskinsWJ, eds. Non-Hodgkin lymphoma Cancer Management: A Multidisciplinary Approach. 13th ed. Lawrence, KS: UBM Medica; 2010:739-794.
  17.  Keller CE, Nandula S, Fisher J, et al. The Spectrum of B-Cell Non-Hodgkin Lymphomas with Dual IgH BCL2 and BCL6 Translocations. Am J Clin Pathol 2008;130(2):193-201. [PubMed]
  18.  Chang ST, Lu YH, Lu CL, et al. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumors. Histopathology 2013;63(1):1-12. [PubMed]
  19.  Keni Gu, Kai Fu, Smrati Jain, et al. The t(14;18) is associated with germinal center-derived diffuse large B-Cell lymphoma and Is a strong predictor of outcome. Clin Cancer Res 2003;9(6)2133-9. [PubMed]
  20.  Otake Y, Soundararajan S, Sengupta TK, et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 2007;109(7):306-75. [PubMed]
  21.  Snuderl M1, Kolman OK, Chen YB, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 2010;34(3):327-40. [PubMed]
  22.  Sungalee S, Mamessier E, Morgado E, et al. Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. J Clin Invest 2014;124(12):5337-51. [PubMed]
  23.  Johnson N, Savage K, Ludkovski O, Ben Neriah S. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 2009:114(11). [Abstract/Full-text]
  24.  Batstone PJ, Goodlad JR. Efficacy of screening the intermediate cluster region of the bcl2 gene in follicular lymphomas by PCR. J Clin Pathol 2005;58(1):81-82. [Abstract/Full-text]
  25.  Hirt C, Camargo M, Yu KJ, Hewitt SM, Dölken G, Rabkin CS. Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood. Leukemia & Lymphoma 2015;56:2625-2629. [Abstract/Full-text]
  26. Shuga J, Zeng Y, Novak R, et al. Single molecule quantitation and sequencing of rare translocations using microfluidic nested digital PCR. Acids Res 2013;41(16):e159. [PubMed]
  27. Baccarelli A, Hirt G,  Pesatori A, Consonni D,  Patterson D. t(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis 2006;27(10): [Abstract/Full-text]
  28. Nambiar M,  Raghavan C. Chromosomal translocations among the healthy human population: implications in oncogenesis. Cellular and Molecular Life Sciences 2013;70;1381-1392. [Abstract/Full-text]

READ THE FULL ARTICLE

1. Access this article through OpenAthens

2. Access this article  through your login credentials or your institution

Get Access

3. Purchase this article at rate $55.00 and received Full-Text/PDF
You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use. Use the coding below to purchase your article as PDF by credit card, debit card, payball will be asked to supply your billing card information. Before continue with your purchase please read carefully BM–Publisher terms and conditions of purchase.

Purchase Article

For any technique error please contact us and will be response to sending purchase article by email.

Thank you for visiting Journal of Cellular Cancer.  * = Required fields

    Your Name (required)

    Your Email (required)

    Subject

    Your Message